Skip to main content

Acta Neuropathologica

Ausgabe 5/2015

Inhalt (9 Artikel)

Open Access Original Paper

Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies

Jens Wagner, Sybille Krauss, Song Shi, Sergey Ryazanov, Julia Steffen, Carolin Miklitz, Andrei Leonov, Alexander Kleinknecht, Bettina Göricke, Jochen H. Weishaupt, Daniel Weckbecker, Anne M. Reiner, Wolfgang Zinth, Johannes Levin, Dan Ehninger, Stefan Remy, Hans A. Kretzschmar, Christian Griesinger, Armin Giese, Martin Fuhrmann

Open Access Original Paper

PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia

Helois Radford, Julie A. Moreno, Nicholas Verity, Mark Halliday, Giovanna R. Mallucci

Original Paper

Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43

Adam K. Walker, Krista J. Spiller, Guanghui Ge, Allen Zheng, Yan Xu, Melissa Zhou, Kalyan Tripathy, Linda K. Kwong, John Q. Trojanowski, Virginia M.-Y. Lee

Original Paper

Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS

Yazi D. Ke, Annika van Hummel, Claire H. Stevens, Amadeus Gladbach, Stefania Ippati, Mian Bi, Wei S. Lee, Sarah Krüger, Julia van der Hoven, Alexander Volkerling, Andre Bongers, Glenda Halliday, Nikolas K. Haass, Matthew Kiernan, Fabien Delerue, Lars M. Ittner

Original Paper

Rab1-dependent ER–Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS

Kai Y. Soo, Mark Halloran, Vinod Sundaramoorthy, Sonam Parakh, Reka P. Toth, Katherine A. Southam, Catriona A. McLean, Peter Lock, Anna King, Manal A. Farg, Julie D. Atkin

Open Access Original Paper

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies

James P. Fuller, Jeffrey B. Stavenhagen, Søren Christensen, Fredrik Kartberg, Martin J. Glennie, Jessica L. Teeling

Original Paper

Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models

Yvonne Bouter, Jose Socrates Lopez Noguerola, Petra Tucholla, Gabriela A. N. Crespi, Michael W. Parker, Jens Wiltfang, Luke A. Miles, Thomas A. Bayer

Original Paper

PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk

Svetlana M. Stamatovic, Nikola Sladojevic, Richard F. Keep, Anuska V. Andjelkovic

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.